Valuation (93%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.23 | N/A |
| PEG Ratio (TTM) | 1.46 | N/A |
| P/S Ratio (TTM) | 0.30 | N/A |
| P/B Ratio (TTM) | 1.76 | N/A |
| P/FCF Ratio (TTM) | 7.64 | N/A |
| Price to 5YR AVG Earnings Ratio | 6.77 | N/A |
| Price to 5YR AVG FCF Ratio | 5.64 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.49% | N/A |
| ROE (TTM) | 26.70% | N/A |
| Net Profit Margin (TTM) | 4.13% | N/A |
| ROIC 5YR AVG | 14.01% | N/A |
Growth (37%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -94.61% | 12.70% | 5.19% |
| Revenue | 0.40% | -0.20% | -0.64% |
| Net Income | 5.68% | 10.01% | 2.74% |
| Cash Flow | 19.23% | -12.11% | 4.37% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.20 | N/A |
| Quick Ratio (TTM) | 0.45 | N/A |
| D/E Ratio (TTM) | 1.56 | N/A |
| Interest Coverage (TTM) | 3.71 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 2.65 | N/A |
| LTL to 5YR AVG FCF | 7.40 | N/A |
| Shares Outstanding Growth 5YR AVG | -2.76% | N/A |